Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of ...

Zimmer Biomet has scored an FDA clearance for a new component of its total knee replacement offering, aimed at patients who may be sensitive to certain metals or bone cement. The Persona SoluTion ...

the Oxford Cementless Partial Knee has become the preferred partial knee implant for Zimmer Biomet's European customers.5 As part of the U.S. nationwide launch in Q1 2025, Zimmer Biomet will ...

After hours: December 18 at 5:59:59 PM EST ...

WARSAW, Ind., Nov. 25, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) Premarket ...

Since its initial launch in England in 2004, the Oxford Cementless Partial Knee has become the preferred partial knee implant for Zimmer Biomet’s European customers. 5 As part of the U.S. nationwide ...

Zimmer Biomet has secured the US Food and Drug Administration (FDA) 510(k) clearance for its total knee implant component, Persona SoluTion porous plasma spray (PPS) femur. It provides an ...

Medical technology company Zimmer Biomet has received approval from the U.S. Food and Drug Administration for its Oxford cementless partial knee, making it the first implant of its kind available ...

Zimmer Biomet (ZBH) Holdings announced U.S. FDA Premarket Approval Application Supplement approval for the Oxford Cementless Partial Knee. The approval is based on safety and effectiveness data ...